Prophylactic TNF blockade reduces autoimmune toxicity

Abstract

In a study published in Nature, Perez-Ruiz et al. report that prophylactic tumour necrosis factor (TNF) blockade reduces gastrointestinal immune-related adverse events in mice treated with dual immune-checkpoint inhibition, providing a clear preclinical rationale for the clinical investigation of such strategies.